News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Rafaella Muratori: Ever wonder why developing countries don’t publish as much?
Photo taken from Rafaella Muratori/X
Jun 10, 2024, 07:44

Rafaella Muratori: Ever wonder why developing countries don’t publish as much?

Rafaella Muratori, Bone Marrow Transplant Specialist at Hospital Nossa Senhora das Graças, made the following post on X:

“Ever wonder why developing countries don’t publish as much? This is me reviewing old charts friday at 9 p.m. after a full work day. Paid research time is a huge privilege!”

Source: Rafaella Muratori/X

academic publishing cancer chart review developing countries Medical Research OncoDaily Oncology paid research time publishing disparity Rafaella Muratori research challenges research privilege research workload work-life balance
Special Coverage
Blog
Oct 5, 2024, 15:22
Chiesi Group announced the operational launch of its biotech centre of excellence in Italy
Blog
Oct 5, 2024, 15:16
Sidra Naz: I have 3 accepted abstracts as the first presenting author at this year's ASH Conference
Blog
Oct 5, 2024, 14:44
Folakemi Odedina: How diet, nutrition and physical activity affect colorectal cancer risk and survival at the UICC Congress
Blog
Oct 5, 2024, 14:38
Evandro de Azambuja: Discussing Costs of Cancer Treatments, Fertility Preservation, and Right to be Forgotten
Blog
Oct 5, 2024, 14:35
Hayley Jones: The first ever Indonesia International Cancer Conference
Blog
Oct 5, 2024, 14:34
Patrick Hwu: Thank You to Our Incredible Response Teams
Blog
Oct 5, 2024, 14:15
Rohit Loomba: Medicine grand rounds at ⁦UC San Diego Health Sciences⁩
Insight
Oct 5, 2024, 14:14
MD Anderson at ASTRO: Research Highlights Special Edition
Blog
Oct 5, 2024, 13:57
The importance of clinical trials and the role of translational research in SCLC - LUNGevity Foundation
Insight
Oct 5, 2024, 13:35
SI kinase to act as a key signaling mediator of a rare fusion oncogene involved in fibrolamellar carcinoma
Blog
Oct 5, 2024, 13:09
Oncoinfluencers to Follow on Social Media: Dr. Emily Drake
Positive
Oct 5, 2024, 13:07
Jimmy Carter at 100: A Legacy of Resilience and the Power of Immunotherapy